Sources

1. SG Chudnoff, et al. Outpatient Procedure for the Treatment and Relief of Symptomatic Uterine Myomas. Obstetrics and Gynecology, 2013;121(5):1075-82.

2. Marcel Grube, MD, Felix Neis, MD, Sara Y. Brucker, MD, Stefan Kommoss, PhD, Martin Weiss, MD, Sascha Hoffman, MD, Florin-Andrei Taran, MD, Bernhard Krämer, PhD. Uterine fibroids: current trends and strategies. Surg Technol Int. 2019 Mar 18:34. PMID: 30888674

3. Robles, R, Aguirre, V, Argueta, A, Guerrero, MR, Laparoscopic radiofrequency volumetric thermal ablation of uterine myomas with 12 months of follow-up, Int J Gynecol Obstet 2013; 120:65-9.

4. Braun, KM, Sheridan, M, Latif, EZ, Regush, L, Maksymowicz, A, Weins, L, Sanders, BH, (2016). Surgeons’ early experience with the AcessaTM procedure: gaining proficiency with new technology. International journal of women’s health, 8, 669-675. doi:10.2147/IJWH.S119265

5. Linda D Bradley, MD, Resad P. Pasic, MD, Larry E Miller, PhD. Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies. J Laparoendosc Adv Surg Tech A 2019 Nov 8; doi:10.1089/lap.2019.0550

6. Leteo Lin, MD, Haocheng Ma, MD, Jian Wang, MD, Haitao Guan, MD, Min Yang, MD, Xiaoqiang Tong, MD and Yinghua Zou, MD. Quality of life, adverse events and reintervention outcomes after radiofrequency ablation for symptomatic uterine fibroids: a meta-analysis. J Minim Invasive Gynecol 2019;26(3):409—416. Doi:10.1016/j.jmig.2018.09.772: PMID: 30253997

7. Yelena Havryliuk, MD, Robert Setton, MD, John Carlow, EdD, MPH, Barry D. Shaktman, MD, Management of symptomatic fibroids: review and meta-analysis of the literature (2006—2016), Journal of the Society of Laparoendoscopic Surgeons, Vol. 21 (3) Jul—Sept 2017

8. Jay M. Berman, MD, Richard S. Guido, MD, José Gerardo Garza Leal, MD, Rodolfo Robles Pemueller, MD, Fredrick S. Whaley, PhD, Scott G. Chudnoff, MD, MS, Three years’ outcome from the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas, The Journal of Minimally Invasive Gynecology, 2014; 21(5):767.

9. Sara Y. Brucker, Markus Hahn, Dorit Kraemer, Florin Andrei-Taran, Keith B. Isaacson, Bernhard Krämer. Initial results from a randomized controlled study of laparoscopic radiofrequency volumetric thermal ablation of fibroids and laparoscopic myomectomy, International Journal of Gynecology and Obstetrics, 2014 available online at http://authors.elsevier.com/sd/article/S0020729214001040

10. Acessa ProVu Instructions for Use, ProVu Users Guide PL-01-0040

11. Interviews with Dr. Bruce Lee, inventor of the idea of using laparoscopic radiofrequency ablation for fibroids

12. Acessa Health Corporate data, proprietary system

13. Mayo Clinic—Uterine Fibroids—www.mayoclinic.org/diseases-conditions/uterine-fibroids/symptoms-causes/syc-20354288

14. Internal Analysis based on US Census population information total population women aged 15-64 (104 million women), Kaiser Family Foundation information for the number of Medicaid (25 million) and commercial lives (79 million), Wakely Actuarial Firm claims analysis for Fibroid ICD-10 diagnosis code prevalence in commercial claim data (6% of women in data set sought care for fibroid related diagnosis code) and internal assumption for Medicaid prevalence (6%).

15. Julian A Gingold, MD, Ndeye-Aicha Gueye, MD Tommaso Falcone, MD, Minimally invasive approaches to myoma management. J Minim Invasive Gynecol. 2018 Feb; 25(2):237—250. PMID: 28734973

16. Borah, Bijan J. et al. The impact of uterine leiomyomas: a national survey of affected women, American Journal of Obstetrics & Gynecology, October 2013, Volume 209, Issue 4, 319.e1—319.e20

17. Baird DD, Dunson DB, Hill MV, Cousins D, Schechtman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003; 188:100—107.

18. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006. Uterine fibroids: Overview. 2014 Oct 22 [Updated 2017 Nov 16]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279535/

19. Mayo Clinic—Endometriosis https://www.mayoclinic.org/diseases-conditions/endometriosis/symptoms-causes/syc-20354656

20. Health Line—Polyps https://www.healthline.com/health/polyps

21. Mayo Clinic—Adenomyosis https://www.mayoclinic.org/diseases-conditions/adenomyosis/symptoms-causes/syc-20369138

22. Mayo Clinic—Cysts https://www.mayoclinic.org/diseases-conditions/ovarian-cysts/symptoms-causes/syc-20353405

23. Leppert PC, Jayes FL, Segars JH. The extracellular matrix contributes to mechanotransduction in uterine fibroids. Obstet Gynecol Int. 2014;2014:783289. doi:10.1155/2014/783289

24. Lee BB, Yu SP. Radiofrequency Ablation of Uterine Fibroids: a Review. Curr Obstet Gynecol Rep. 2016;5(4):318—324. doi:10.1007/s13669—016—0183—x

25. Healthline—Myomectomy https://www.healthline.com/health/womens-health/myomectomy#recovery

26. Clarke-Pearson, DL, & Geller, EJ (2013). Complications of Hysterectomy: Obstetrics & Gynecology. Retrieved from https://journals.lww.com/greenjournal/Abstract/2013/03000/Complications_of_Hysterectomy.23.aspx

27. Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids

28. Amanda Harrington, Nicole G. Bonine, Erika Banks, Vanessa Shih, Dana Sta key-Mailey, Rupali M. Fuldeore, Binglin Yue, Jiatao Michael Ye, Jamie T. Ta, and Patrick Gillard, Journal of Managed Care & Specialty Pharmacy, 2020 26:1—a Suppl, S2—S10 https://www.jmcp.org/doi/10.18553/jmcp.2020.26.1-a.s2

29. Bernhard Krämer, Markus Hahn, Florin A. Taran, Dorit Kraemer, Keith B. Isaacson, Sara Y. Brucker, Interim analysis of a randomized controlled trial comparing laparoscopic radiofrequency volumetric thermal ablation of uterine fibroids with laparoscopic myomectomy, International Journal of Gynecology and Obstetrics, 133 (2016) 206—211. See http://www.ijgo.org/article/S0020-7292 (15)00767—5/pdf

30. AAGL Patient Information Sheet Laparoscopic Radiofrequency Ablation

31. Magnay, J.L., O’Brien, S., Gerlinger, C. et al. A systematic review of methods to measure menstrual blood loss. BMC Women’s Health 18, 142 (2018). https://doi.org/10.1186/s12905-018-0627-8

32. Reidy, J., Hacking, N., McLucas, B (Ed.). (2014). Radiological interventions in obstetrics and gynaecology. Springer.

33. Acessa ProVu Instructions for Use, ProVu Users Guide PL—01—0040

34. Robles, R, Aguirre, V, Argueta, Al, Guerrero, MR, Laparoscopic radiofrequency volumetric thermal ablation of uterine myomas with 12 months of follow-up, Int J Gynecol Obstet, 2013; 120:65-9

35. Leteo Lin, MD, Haocheng Ma, MD, Jian Wang, MD, Haitao Guan, MD, Min Yang, MD, Xiaoqiang Tong, MD and Yinghua Zou, MD. Quality of life, adverse events and reintervention outcomes after radiofrequency ablation for symptomatic uterine fibroids: a meta-analysis. J Minim Invasive Gynecol, 2019;26(3):409—416. Doi:10.1016/j.jmig.2018.09.772: PMID: 30253997

36. Linda D Bradley, MD, Resad P. Pasic, MD, Larry E Miller, PhD. Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies. J Laparoendosc Adv Surg Tech A, 2019 Nov 8; doi:10.1089/lap.2019.0550

37. Braun, K. M., Sheridan, M., Latif, E. Z., Regush, L., Maksymowicz, A., Weins, L., … Sanders, B. H. (2016). Surgeons’ early experience with the AcessaTM procedure: gaining proficiency with new technology. International journal of women’s health, 8, 669—675. doi:10.2147/IJWH.S119265

38. Interviews with Dr. Bruce Lee, inventor of the idea of using laparoscopic radiofrequency ablation for fibroids

39. Acessa Health Corporate data, proprietary system

40. Tsuzuki, Y., Tsuzuki, S., Wada, S., Fukushi, Y., & Fujino, T. (2019, January). Recovery of quality of life after laparoscopic myomectomy. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30255650

41. Evelien M. Sandberg, MD, Fokkedien H. M. P. Tummers, Sarah L. Cohen, MD, MPH, Lukas van den Haak, MD, Olaf M. Dekkers, MD, PhD, Frank Willem Jansen, MD, PhD. Reintervention risk and quality of life outcomes after uterine sparing interventions for fibroids: a systematic review and meta-analysis, Fertil Steril 2018 Apr; 109(4):698—707. doi:10/1016/j.fertnstert.2017.11.033. PMID: 29653718

42. Fertil Steril 2018 Apr; 109(4):698-707. doi: 10/1016/j.fertnstert.2017.11.033. PMID: 29653718

43. Wright, Jason D et al. “Nationwide trends in the performance of inpatient hysterectomy in the United States.” Obstetrics and gynecology vol. 122,2 Pt 1 (2013): 233-41. doi:10.1097/AOG.0b013e318299a6cf

44. McIlwaine P, McElhinney B, Karthigasu KA, Hart R, A Prospective Study of the Use of the MyoSure Resectoscope to Manage Endometrial Polyps in an Outpatient Setting. The Australian and New Zealand Journal of Obstetrics and Gynaecology. October 2015

45. Gupta JK, Sinha A, M AL, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database of Systematic Reviews. 2014;(12). doi:10.1002/14651858.CD005073.pub4

46. Pron G, Mocarski E, Bennett J, et al. Tolerance, hospital stay, and recovery after uterine artery embolization for fibroids: the Ontario Uterine Fibroid Embolization Trial. Journal of Vascular and Interventional Radiology : JVIR. 2003 Oct;14(10):1243-1250. DOI: 10.1097/01.rvi.0000092664.72261.f9.

47. Mayo Clinic – Robotic Hysterectomy https://www.mayoclinic.org/tests-procedures/robotic-hysterectomy/about/pac-20384544